TransMedics
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, TransMedics sits in the top decile of US sponsors by registered trial count (#668 of 15,742 sponsors by registered trial count).
TransMedics: 23 sponsored US clinical trials, 4 recruiting.
TransMedics sponsors 23 registered US clinical trials on ClinicalTrials.gov, 4 of them currently recruiting, and 13 completed. The most-studied condition in this pipeline is Heart Transplant, with 6 trials.
Top-decile sponsor footprint
TransMedics ranks in the top decile of sponsors by registered trial count (#668 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
13 of 15 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
23 total, page 1 of 1
Enhancing Heart Allograft Function With the OCS Heart System Trial
NCT07145515
US National TOP Registry
NCT06513091
US National OCS Heart Perfusion (OHP) Registry
NCT05915299
US National OCS Liver Perfusion (OLP) Registry
NCT05940857
OCS Liver Perfusion (OLP) Post-Approval Registry
NCT05074160
OCS Heart Perfusion Post-Approval Registry
NCT05047068
OCS DCD Heart + CAP Continued Follow-Up
NCT05741723
OCS™ Lung TOP Registry For Donor Lungs for Transplantation
NCT03639025
Donor After Circulatory Death Heart CAP Trial
NCT04615182
OCS Liver DCD Trial
NCT04194437
OCS Liver PROTECT Continued Access Protocol (CAP) Continuation Post-Approval Study
NCT05096754
OCS Liver PROTECT Continued Access Protocol
NCT04186221
Donors After Circulatory Death Heart Trial
NCT03831048
INSPIRE Continuation Post-Approval Study
NCT03868904
Heart EXPAND Continued Access Protocol
NCT03835754
OCS Lung Expand Post-Approval Study - Expand Follow-Up Data Collection
NCT04194398
OCS Lung System EXPAND II Trial
NCT03343535
OCS Liver PROTECT Trial: Preserving and Assessing Donor Livers for Transplantation
NCT02522871
OCS Liver PROTECT Continuation Post-Approval Study
NCT05096741
International EXPAND Heart Pivotal Trial
NCT02323321
International EXPAND Lung Pivotal Trial
NCT01963780
International Randomized Study of the TransMedics Organ Care System (OCS Lung) for Lung Preservation and Transplantation
NCT01630434
Randomized Study of Organ Care System Cardiac for Preservation of Donated Hearts for Eventual Transplantation
NCT00855712
Therapeutic Areas
What is open in the TransMedics pipeline
4 recruiting of 23 indexed (17% open); 13 completed (57%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Heart Transplant (6 trials), 7 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
TransMedics: open-pipeline peers nationwide
Peers matched on 23 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
TransMedics sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 23 trials (± recruiting share)
- AMAG Pharmaceuticals · 23 trials · 9% recruiting
- AtriCure · 23 trials · 22% recruiting
- Cara Therapeutics · 23 trials · 0% recruiting
- Craig L Slingluff, Jr · 23 trials · 4% recruiting
Sponsors near 17% open enrollment (± trial volume)
- ImmunityBio · 17% recruiting · 46 trials
- Old Dominion University · 17% recruiting · 23 trials
- Texas Tech University · 17% recruiting · 69 trials
- Memorial Sloan Kettering Cancer Center · 17% recruiting · 1,884 trials
Related
What to do with this TransMedics page
23 registered trials is a research-attention snapshot, not an endorsement of TransMedics or any single study.
- 4 of TransMedics's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Heart Transplant is the condition TransMedics studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Heart Transplant trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
TransMedics pipeline card: 23 registered trials from official public datasets.Report a data error.